Literature DB >> 18567522

Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.

F Tanriverdi1, H Yapislar, Z Karaca, K Unluhizarci, C Suer, F Kelestimur.   

Abstract

CONTEXT: Impaired cognitive performance has been demonstrated in adults with GH deficiency and acromegaly by using different neuropsychological tests. P300 event related potential (ERP) application is a well established neurophysiological approach in the assessment of cognitive performance.
OBJECTIVES: Evaluation of cognitive performance by using P300 ERPs has not been reported in acromegaly, and the comparisons of the P300 ERPs between the patients with GH deficiency and GH excess have not been done yet. Therefore present study was designed to investigate the effects of GH deficiency and GH excess on cognitive performance by using P300 ERPs. DESIGN AND METHODS: The study comprised 19 patients with severe GH deficiency, 18 acromegalic patients and 16 age, education and sex matched healthy controls. Baseline auditory ERPs were obtained at Fz (frontal), Cz (central), Pz (parietal) and Oz (occipital) electrode sites in GH deficient group, GH excess group and control group.
RESULTS: There was a significant difference between mean serum IGF-I levels in the GH deficient and acromegalic patients (48+/-38 ng/ml and 742+/-272 ng/ml, respectively) (P=0.01). The mean P300 latency of the patients with GH deficiency was significantly (P=0.0001) prolonged when compared with that of normal controls and acromegalic patients at all electrode sites. The mean P300 amplitude of the patients with acromegaly was significantly (P=0.005) lower when compared with that of normal controls and GH deficient patients at all electrode sites.
CONCLUSIONS: Using ERPs recordings, the present study indicates the prolongation of P300 latencies in patients with severe GH deficiency and reduction of P300 amplitudes in patients with acromegaly. This study provides the electrophysiological evidence for the presence of cognitive dysfunction in both GH deficiency and GH excess, and different components of the cognitive performance are impaired in these conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567522     DOI: 10.1016/j.ghir.2008.05.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  11 in total

1.  Cognitive function in acromegaly: description and brain volumetric correlates.

Authors:  Caroline Sievers; P G Sämann; H Pfister; C Dimopoulou; M Czisch; J Roemmler; J Schopohl; G K Stalla; J Zihl
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

2.  Perception of health and cognitive dysfunction in acromegaly patients.

Authors:  Iris Crespo; Susan M Webb
Journal:  Endocrine       Date:  2014-03-25       Impact factor: 3.633

3.  Evidence of dysexecutive syndrome in patients with acromegaly.

Authors:  Shaobo Shan; Lingling Fang; Jia Huang; Raymond C K Chan; Guijun Jia; Weiqing Wan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

4.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

5.  General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers.

Authors:  Ozlem Haliloglu; Burak Dogangun; Bahar Ozcabi; Hanife Ugur Kural; Fatma Ela Keskin; Hande Mefkure Ozkaya; Fatma Colkesen Pamukcu; Elif Bektas; Burc Cagri Poyraz; Hakan Buber; Olcay Evliyaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

6.  Executive functioning and quality of life in acromegaly.

Authors:  Emilia Solomon; Dumitru Brănișteanu; Andrei Dumbravă; Radu Gheorghe Solomon; Lorànt Kiss; Mihai Glod; Cristina Preda
Journal:  Psychol Res Behav Manag       Date:  2019-01-03

Review 7.  Growth Hormone and the Auditory Pathway: Neuromodulation and Neuroregeneration.

Authors:  Joaquín Guerra Gómez; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

8.  Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegaly.

Authors:  Juan Francisco Martín-Rodríguez; Ainara Madrazo-Atutxa; Eva Venegas-Moreno; Pedro Benito-López; María Ángeles Gálvez; David A Cano; Francisco J Tinahones; Elena Torres-Vela; Alfonso Soto-Moreno; Alfonso Leal-Cerro
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Mallory M Kerner; Howard Tung; Roger L Waite; John Schoolfield; Kenneth Blum
Journal:  BMC Res Notes       Date:  2009-07-07

10.  P300 aberration in first-episode schizophrenia patients: a meta-analysis.

Authors:  Yao-qin Qiu; Yun-xiang Tang; Raymond C K Chan; Xin-yang Sun; Jia He
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.